The Oklahoma ACE, comprised of 26 investigators from diverse clinical and research backgrounds, partners nationally and internationally known, Oklahoma-based clinical and basic science investigators to collaboratively study diverse aspects of autoimmunity. The central theme of our Oklahoma ACE Basic Science Program is to partner basic investigation with clinical lines of inquiry to understand the biology of autoimmune disease flares to aid diagnosis, clinical trial design, therapeutic development and treatment selection to improve the lives of patients with autoimmune diseases. Through exploration of heightened immune dysregulation closely associated with disease flares at the systemic, cellular and molecular levels, we will identify biologic mechanisms which are important in disease pathogenesis and in clinical disease activity. Our principal project focuses on novel mechanisms of gene expression regulation of TNFAIP3, a potent negative regulator of NF-kB signaling, which has been identified and confirmed as a risk gene for a number of waxing and waning autoimmune diseases. The collaborative project tests hypotheses of regulatory, inflammatory and TNFR exosomal dysregulated immune process association with impending SLE disease flare, as well as provides novel collaborative opportunities to test additional mechanisms of SLE disease activity and to test confirmed flare mechanisms across other autoimmune diseases. Our pilot project will assess mechanisms of multiple sclerosis relapse by examining unique clonal representation through T cell receptor characterization and expansion in CSF and peripheral blood. The overarching goals of our Oklahoma ACE are to understand the pathogenic mechanisms of autoimmune disease flares within and across autoimmune disorders.
Our aims foster integration of a multidisciplinary group to study fundamental aspects of autoimmunity, fortify and expand this nucleus through common educational forums, cultivate and expand ACE collaborative scientific interactions, provide the administrative foundation to Oklahoma ACE investigators, and expand integration of our local expertise in genetics, genomics, epigenetics, various aspects of immunology, analytic methodologies and novel clinical trial design to the national ACE Network.

Public Health Relevance

Despite advances in autoimmune disease research, little is known about the mechanisms of disease flares. These flares often result in increased disease severity and decreased quality of life for autoimmune disease patients. Our Oklahoma ACE partners basic science and clinical investigators to examine the pathogenic mechanisms of autoimmune disease flares within and across autoimmune disorders.

Agency
National Institute of Health (NIH)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI082714-06
Application #
8679242
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Johnson, David R
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Morris, D L; Fernando, M M A; Taylor, K E et al. (2014) MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun 15:210-7
Rasmussen, Astrid; Ice, John A; Li, He et al. (2014) Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort. Ann Rheum Dis 73:31-8
Ritterhouse, Lauren L; Lu, Rufei; Shah, Hemangi B et al. (2014) Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European-American healthy controls. PLoS One 9:e94500
Young, K A; Terrell, D R; Guthridge, J M et al. (2014) Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls. Lupus 23:360-9
Guthridge, Joel M; Lu, Rufei; Sun, Harry et al. (2014) Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am J Hum Genet 94:586-98
Munroe, Melissa E; Vista, Evan S; Guthridge, Joel M et al. (2014) Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis Rheumatol 66:1888-99
James, Judith A (2014) Clinical perspectives on lupus genetics: advances and opportunities. Rheum Dis Clin North Am 40:413-32, vii
Kim-Howard, Xana; Sun, Celi; Molineros, Julio E et al. (2014) Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations. Hum Mol Genet 23:1656-68
Sakurai, Daisuke; Zhao, Jian; Deng, Yun et al. (2013) Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression. PLoS Genet 9:e1003870
Manku, Harinder; Langefeld, Carl D; Guerra, Sandra G et al. (2013) Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. PLoS Genet 9:e1003554

Showing the most recent 10 out of 48 publications